1. Home
  2. AHH vs LQDA Comparison

AHH vs LQDA Comparison

Compare AHH & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AHH
  • LQDA
  • Stock Information
  • Founded
  • AHH 1979
  • LQDA 2004
  • Country
  • AHH United States
  • LQDA United States
  • Employees
  • AHH N/A
  • LQDA N/A
  • Industry
  • AHH Real Estate
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AHH Finance
  • LQDA Health Care
  • Exchange
  • AHH Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • AHH 835.5M
  • LQDA 935.3M
  • IPO Year
  • AHH 2013
  • LQDA 2018
  • Fundamental
  • Price
  • AHH $10.99
  • LQDA $11.09
  • Analyst Decision
  • AHH Buy
  • LQDA Strong Buy
  • Analyst Count
  • AHH 2
  • LQDA 8
  • Target Price
  • AHH $11.75
  • LQDA $27.14
  • AVG Volume (30 Days)
  • AHH 923.8K
  • LQDA 950.2K
  • Earning Date
  • AHH 11-04-2024
  • LQDA 11-05-2024
  • Dividend Yield
  • AHH 7.46%
  • LQDA N/A
  • EPS Growth
  • AHH N/A
  • LQDA N/A
  • EPS
  • AHH N/A
  • LQDA N/A
  • Revenue
  • AHH $735,262,000.00
  • LQDA $14,840,000.00
  • Revenue This Year
  • AHH N/A
  • LQDA N/A
  • Revenue Next Year
  • AHH $3.87
  • LQDA $234.65
  • P/E Ratio
  • AHH N/A
  • LQDA N/A
  • Revenue Growth
  • AHH 23.67
  • LQDA N/A
  • 52 Week Low
  • AHH $9.81
  • LQDA $6.04
  • 52 Week High
  • AHH $13.11
  • LQDA $16.99
  • Technical
  • Relative Strength Index (RSI)
  • AHH 43.07
  • LQDA 56.55
  • Support Level
  • AHH $11.09
  • LQDA $10.69
  • Resistance Level
  • AHH $11.26
  • LQDA $11.84
  • Average True Range (ATR)
  • AHH 0.18
  • LQDA 0.52
  • MACD
  • AHH 0.05
  • LQDA 0.06
  • Stochastic Oscillator
  • AHH 49.30
  • LQDA 60.11

About AHH Armada Hoffler Properties Inc.

Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. They lease our properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting and real estate services. It generates maximum revenue from the general contracting and real estate services segment.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: